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Background: Csd6 is one of the cell shape-determining proteins in H. pylori.
Results: The active site of Csd6 is tailored to function as an L,D-carboxypeptidase in the peptidoglycan-trimming process.
Conclusion: Csd6 constitutes a new family of L,D-carboxypeptidase.
Significance: The substrate limitation of Csd6 is a strategy that H. pylori uses to regulate its helical cell shape and motility.
Helicobacter pylori causes gastrointestinal diseases, including
gastric cancer. Its high motility in the viscous gastric mucosa
facilitates colonization of the human stomach and depends on
the helical cell shape and the flagella. InH. pylori, Csd6 is one of
the cell shape-determining proteins that play key roles in alter-
ation of cross-linking or by trimming of peptidoglycan muro-
peptides. Csd6 is also involved in deglycosylation of the flagellar
protein FlaA. To better understand its function, biochemical,
biophysical, and structural characterizations were carried out.
We show that Csd6 has a three-domain architecture and exists
as a dimer in solution.TheN-terminal domainplays a key role in
dimerization. The middle catalytic domain resembles those of
L,D-transpeptidases, but its pocket-shaped active site is uniquely
defined by the four loops I to IV, among which loops I and III
show themost distinct variations from the known L,D-transpep-
tidases. Mass analyses confirm that Csd6 functions only as an
L,D-carboxypeptidase and not as an L,D-transpeptidase. The
D-Ala-complexed structure suggests possible binding modes of
both the substrate and product to the catalytic domain. The
C-terminal nuclear transport factor 2-like domain possesses a
deep pocket for possible binding of pseudaminic acid, and in
silicodocking supports its role indeglycosylationof flagellin.On
the basis of these findings, it is proposed thatH. pyloriCsd6 and
its homologs constitute a new family of L,D-carboxypeptidase.
This work provides insights into the function of Csd6 in regu-
lating the helical cell shape and motility ofH. pylori.
Helicobacter pylori is a spiral-shaped Gram-negative bacte-
rium that colonizes the upper gastrointestinal tract in approx-
imately half of the world’s human population. Its infection of
the gastric mucosa is associated with various gastric diseases,
including chronic gastritis, peptic ulcer, mucosa-associated
lymphoid tissue lymphoma, and gastric adenocarcinoma (1, 2).
H. pylori is regarded as a primary factor for gastric cancer devel-
opment (1) and was classified as a group I carcinogen by the
International Agency for Research on Cancer of the World
Health Organization. In recent years, H. pylori infection has
also been implicated with some extra-digestive diseases (3).
Typical treatment regimens for eradicating H. pylori consist of
a proton pump inhibitor (for example, omeprazole) and the
antibiotics such as clarithromycin and amoxicillin (or metron-
idazole). However, increasing drug resistance in H. pylori
requires the discovery of new antibiotics (4).
High motility ofH. pylori is important for its colonization of
the human stomach and its survival in the viscous gastric
mucosa (5–7). The helical cell shape of H. pylori is believed to
facilitate penetration of the viscous epithelialmucous layer via a
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cork-screwing mechanism (8–10). Several H. pylori mutants
with altered cell shapes exhibited attenuated colonization (11).
The peptidoglycan layer, the major component of the bacterial
cell wall, plays an essential role in withstanding the turgor pres-
sure and in determining the cell shape (12, 13). It is made of
linear polysaccharide chains that consist of alternating -1,4-
linked N-acetylglucosamine-N-acetylmuramic acid disaccha-
ride units, with a pentapeptide linked toN-acetylmuramic acid
(14). In H. pylori, the pentapeptide sequence is L-Ala1--D-
Glu2-mDAP3-D-Ala4-D-Ala5 (or -Gly5), wheremDAP5 refers to
meso-2,6-diaminopimelate, and the neighboring peptides are
cross-linked exclusively by the 433 linkage between the main
chain of D-Ala4 from one strand and the side chain of mDAP3
from another strand (15) to form a mesh-like structure termed
peptidoglycan sacculus (16, 17). Colonization and infection by
H. pylori also rely on the ability of the bacterium to move
toward the part of gastric mucosa with more neutral pH.
Besides the helical morphology, powerful flagella of H. pylori
are responsible for its high motility through the viscous gastric
mucous layer (5–7). The flagella provide a propulsive torque as
well as a rotarymovement of the cell body; a helical cell shape of
H. pylori generates a corkscrew-like rotation (7–9).
Inmany bacteria, includingH. pylori, the peptidoglycan layer
is remodeled by a number of cell-wall hydrolases as well as
synthetases for the peptidoglycan maturation, regulation of
cell-wall growth, cell division, peptidoglycan turnover and
recycling, cell lysis, and the release of peptidoglycan fragments
for host-pathogen interactions (18). In H. pylori, an amidase
AmiA (19), peptidases Csd1–4, potential regulators Csd5 and
CcmA (20–22), and another peptidase Csd6 (23) are required
to tailor the peptidoglycan layer to generate the helical cell
shape. We have recently reported the crystal structures of both
Csd4 (HP1075 in strain 26695) (24) and Csd3 (HP0506 in strain
26695) (25). Csd4 is a Zn2-dependent D,L-carboxypeptidase
(D,L-CPase) of theM14metallopeptidase family and cleaves the
-D-Glu2-mDAP3 bond of the muramyl tripeptide to produce
the muramyl dipeptide (21, 24). Csd3 (also known as HdpA)
belongs to the M23 metallopeptidase family and has both D,D-
endopeptidase and D,D-carboxypeptidase (D,D-CPase) activities
(22). Csd6 (encoded by the hp0518 gene in H. pylori 26695
strain) was identified as another member of the peptidoglycan
trimming pathway and also a cell-shape determinant of H.
pylori (23). The transposon mutant H. pylori with the disrup-
tion of the csd6 gene or the csd6 deletion mutant displayed a
straight rod shape and an increase in tetrapeptide-containing
muropeptides (23). Incubation of the recombinant hexahisti-
dine-tagged Csd6 with tetrapeptide-rich sacculi from the
csd1csd6mutantH. pylori resulted in complete conversion of
the monomeric tetrapeptides to tripeptides (23). In Campylo-
bacter jejuni, another helically shaped gastrointestinal patho-
gen, a homolog of Csd6 has been characterized as an L,D-CPase
and was named as Pgp2 (26). Loss of pgp2 resulted in the mor-
phology defect, changes in the peptidoglycanmuropeptide pro-
file, reduced motility, and moreover, a decreased interaction
with the host (26). Between Csd6 and Pgp2, an overall amino
acid sequence identity of 36% and similarity of 58% exist. Given
the significance ofmDAP-containing muramyl tripeptide as an
agonist for the cytosolic innate immune receptorNod1 (27, 28),
an increased amount of muramyl tripeptide as a result of L,D-
CPase reaction by Pgp2 (or Csd6 fromH. pylori) was suggested
to effect the Nod1 activation and ultimately the NF-B tran-
scriptional activity (26). The complete absence of tripeptide-
containing muropeptides in pgp2 peptidoglycan did indeed
reflect the reduced Nod1 activation, despite no effect in either
intracellular survival or IL-8 secretion (26).
A bioinformatics analysis on the basis of the amino acid
sequence predicts that residues 67–200 of H. pylori Csd6 form
a YkuD domain (formerly called ErfK/YbiS/YcfS/YnhG; “L,D-
transpeptidase” catalytic domain; Pfam 03734) that can possi-
bly catalyze nonclassical 333 cross-linking of peptidoglycan.
TheYkuDdomain-containing L,D-transpeptidases (L,D-TPases)
have been identified in a range of bacteria, including Enterococ-
cus faecium, Bacillus subtilis, andMycobacterium tuberculosis
(7, 26, 29, 30). They generate 333 cross-linkages of peptidogly-
can, instead of 433 cross-linking catalyzed by classical D,D-
transpeptidases, resulting in high level resistance to -lactam
antibiotics (31) or in peptidoglycan remodeling for dormancy
inM. tuberculosis (32). However, the Helicobacter peptidogly-
can layer is cross-linked exclusively by 433 linkages (15, 20,
33). Consistent with the absence of 333 cross-linked muro-
peptides in the H. pylori peptidoglycan sacculus, Csd6 was
shown to exhibit the L,D-CPase activity only with no “transpep-
tidase” cross-linking activity against the muropeptides (23).
However, it still remains unanswered why Csd6 has no “trans-
peptidase” cross-linking activity, despite the presence of a puta-
tive “L,D-TPase” domain and conservation of the catalytic Cys/
His residues.
Inmany bacterial pathogens, flagella are best known for con-
ferring motility and virulence, as well as serving as an export
apparatus for virulence factors (34) and sensing the viscosity of
a medium (35). Flagellar filaments ofH. pylori are composed of
two copolymerized flagellins (FlaA and FlaB) (36), which are
heavily O-glycosylated with pseudaminic acid (Pse5Ac7Ac;
Pse), a sialic acid resembling sugar (37, 38). The regulation of
such post-translational modification is critical for the assembly
of functional flagella (37, 39). Interestingly, a previous work
highlighted the unique role ofH. pyloriG27 Csd6 that involves
deglycosylation of FlaA; the csd6 mutant exhibited altered
motility to facilitate host-cell interaction and superior coloni-
zation (40). It suggests that Csd6 binds Pse molecules or degly-
cosylates O-glycosylated FlaA proteins.
To better understand the molecular function of H. pylori
Csd6, its biochemical, biophysical, and structural characteriza-
tions have been performed in this study. Mass analyses using
the synthetic muramyl peptides indicate that Csd6 functions
only as the L,D-carboxypeptidase (L,D-CPase) and not as the L,D-
transpeptidase (L,D-TPase). Analytical ultracentrifugation and
5 The abbreviations used are: mDAP, meso-2,6-diaminopimelate; D,L-CPase,
D,L-carboxypeptidase; D,D-CPase, D,D-carboxypeptidase; L,D-TPases, L,D-
transpeptidases; L,D-CPase, L,D-carboxypeptidase; Pse, pseudaminic acid;
NTD,N-terminal domain;NTF2, nuclear transport factor 2; EMTS, ethylmer-
cury thiosalicylate; IFD, induced fit docking;Neu5Ac2en, 2-deoxy-2,3-dide-
oxy-N-acetylneuraminic acid; r.m.s., root-mean-square; MALDI-QIT-TOF
MS, matrix-assisted laser desorption/ionization quadrupole ion trap time-
of-flight mass spectrometer; SPR, surface plasmon resonance; ASU, asym-
metric unit; ALEX, alternating-laser excitation; PDB, Protein Data Bank.
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single molecule fluorescence resonance energy transfer (FRET)
analyses indicate that Csd6 exists as a dimer in solution. ACsd6
monomer has a three-domain architecture consisting of the
N-terminal domain (NTD; Val-13–Asn-56), the middle L,D-
CPase domain (Lys-67–Glu-202), and the C-terminal nuclear
transport factor 2-like domain (NTF2-like domain; Thr-209–
Lys-330). The NTD shows very remote structural similarity
to other known protein structures and plays a key role in
dimerization. Themiddle catalytic domain has an overall fold of
the L,D-TPase domain, validating the bioinformatics prediction.
However, here this catalytic domain is referred to as the “L,D-
CPase” domain, because we as well as others show that Csd6
functions only as an L,D-CPase. The Csd6 L,D-CPase domain
resembles those of well characterized L,D-TPases, but its pock-
et-shaped active site is uniquely defined by the four loops I–IV,
among which loops I and III show the most distinct variations
in sequence length and conformation from known L,D-TPases.
The D-Ala-complexed structure suggests possible binding
modes of both the substrate and product to the L,D-CPase
domain. The NTF2-like domain possesses a deep pocket for
possible binding of a hydrophobic ligand such as Pse, and an in
silico docking study supports its role in the control of the gly-
cosylation level of flagellin. This work provides further insights
into the strategy ofH. pylori for regulating its helical cell shape
and motility, which are crucial for its virulence. The reported
structural information would serve as the foundation in a
search for new drug targets to fight infections by H. pylori.
Experimental Procedures
Protein Expression and Purification—The PCR-amplified
csd6 gene from H. pylori 26695 strain, encompassing residues
Val-13–Lys-330 of the gene product (HP0518), was cloned into
the expression vector pET-28b() (Novagen) to express the
recombinant Csd6 protein fused with a His6-containing tag at
its N terminus. It was overexpressed in Escherichia coli
Rosetta2(DE3)pLysS cells using a Luria Broth culture medium.
Protein expression was induced by 0.5 mM isopropyl -D-thio-
galactopyranoside, and the cells were incubated for an addi-
tional 20 h at 18 °C following growth to mid-log phase at 37 °C.
The cells were lysed by sonication in buffer A (50 mM Tris-
HCl, pH 7.9, 500 mM sodium chloride, and 50 mM imidazole)
containing 10% (v/v) glycerol and 1 mM phenylmethylsulfo-
nyl fluoride. The crude lysate was centrifuged at 36,000 g for
1 h. The recombinant Csd6 protein showed a tendency to
aggregate at 4 °C; therefore, it was purified at room temperature
in two column chromatography steps. The supernatant was
applied to an affinity chromatography column of HiTrap
Chelating HP (GE Healthcare), which was previously equili-
brated with buffer A. Upon eluting with a gradient of imidazole
in the same buffer, the Csd6 protein was eluted at 120–150mM
imidazole concentration. The eluted protein was applied to a
HiLoad XK-16 Superdex 200TM column (GE Healthcare),
which was previously equilibrated with 20 mM Tris-HCl, pH
7.9, and 150 mM sodium chloride. Fractions containing the
Csd6 protein were pooled and concentrated to 5.8 mgml1 for
crystallization using a YM10 ultrafiltration membrane (Ami-
con). This construct gave the best crystals in crystallization
experiments. Other constructs were also tried for expression
and crystallization. The Val-13–Lys-330 construct fused with a
C-terminal His6-containing tag was not expressed in E. coli
Rosetta2(DE3)pLysS cells. The constructs covering residues
4–330 or 17–330 were expressed at very low levels and were
insoluble. The construct covering residues 1–330 (full-length)
was expressed in a soluble form, but its crystals diffracted
poorly to 7 Å only.
As a positive control in the L,D-TPase assay, LdtMt2, an L,D-
TPase encoded by the rv2518c gene of M. tuberculosis H37Rv
strain, was used. The N-terminal region (Leu-20–Ala-42) of
LdtMt2 is predicted to form a putative transmembrane helix; the
gene covering residues Ala-55–Ala-408, fused with a His6-con-
taining tag at its C terminus, was cloned into pET-21a()
(Novagen). The recombinant LdtMt2 was overexpressed and
purified essentially as above.
Crystallization, X-ray Data Collection, and Structural
Determination—To solve the phase problem by anomalous dif-
fraction, ethyl mercury thiosalicylate (EMTS)-derivative crys-
tals of the recombinant Csd6were obtained at 23 °C by co-crys-
tallization in the presence of EMTS by the sitting-drop vapor
diffusionmethod. Sitting dropswere prepared bymixing 3l of
the protein solution and 2 l of the reservoir solution (250 mM
potassium nitrate, 18% (w/v) polyethylene glycol 3,350, and 10
mM EMTS). EMTS-derivatized crystals grew to approximate
dimensions of 0.1  0.1  0.05 mm within a few days. Single-
wavelength anomalous diffraction data were collected at 100 K
from an EMTS-derivatized crystal of Csd6 using a cryopro-
tectant solution containing 25% (v/v) glycerol added to the res-
ervoir solution (Table 1). The raw data were processed and
scaled using the program suite HKL2000 (41). Two mercury
sites in two monomers of Csd6 in the crystallographic asym-
metric unit were located using the AutoSol program of the
PHENIX software package (42). The initial phases were further
improved by density modification using the automatic model
building programResolve (43). The initial model was improved
through iterative cycles of model building with Coot (44) and
refinement with Refmac5 of the CCP4 program suite (45, 46).
Native crystals of ligand-freeCsd6were grown at 23 °Cby the
sitting-drop vapor diffusion method. Sitting drops were pre-
pared bymixing 0.5l of the protein solution, 0.1l of a 10-fold
diluted microseed crystal solution, and 0.4 l of the reservoir
solution (1.5% (v/v) Tacsimate, pH 7.0, 22% (w/v) PEG 3,350,
and 100 mM sodium-HEPES, pH 7.5). The microseed crystals
were originally obtained with ligand-free Csd6 using the above
reservoir solution. The crystals grew to approximate dimen-
sions of 0.2  0.1  0.05 mm within a few days. X-ray diffrac-
tion data for the ligand-free Csd6 (Csd6-unbound) were col-
lected at 100 K using a cryoprotectant solution containing 20%
(v/v) glycerol added to the reservoir solution (Table 1). X-ray
diffraction data for the D-Ala-bound Csd6 (Csd6-Ala) were col-
lected at 100 K after the native crystal was preincubated for 2
min in a cryoprotectant solution containing both 20% (v/v)
glycerol and 96 mM D-Ala, which were added to the reservoir
solution (Table 1). The structures of both Csd6-unbound and
Csd6-Ala were determined by molecular replacement with the
programMolRep (47) using the refinedmodel of EMTS-deriva-
tized Csd6. Stereochemistry of the refined models was evalu-
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ated usingMolProbity (48). Data collection and refinement sta-
tistics are given in Table 1.
In Silico Docking—Induced fit docking (IFD) (Schrödinger
Suite Induced Fit Docking protocol; Glide version 5.7, Prime
version 3.0, Schrödinger, LLC, New York) (49, 50) was
employed to predict the binding mode of Pse with consider-
ation of protein flexibility. The Csd6 structure (monomer A
model) was prepared for docking calculations using the Protein
Preparation Wizard implemented in Maestro (version 9.2,
Schrödinger, LLC, New York). The structure of Pse was built in
Maestro 9.2, and the possible conformations of the ligand were
generated using LigPrep (version 2.5, Schrödinger, LLC, New
York). Pse was docked onto Csd6 using the following steps. (i)
The receptor grid ofCsd6was defined as an enclosing box at the
centroid of the key amino acid residues (i.e. Trp-227, Lys-258,
Tyr-297, Lys-313, andGlu-329) in the binding pocket. (ii) In the
initial Glide docking stage, a potential docking with van der
Waals radius scaling of 0.5 for the protein and ligand was per-
formed retaining a maximum number of 20 poses per ligand.
(iii) Residueswithin 5.0Åof ligandposeswere kept free tomove
in the Prime refinement step, and the side chains were further
optimized. (iv) Poses within 30 kcal mol1 of the energy cutoff
in the previous step were re-docked using Glide XP. (v) The
binding energy (IFDScore) for each output pose was computed
as implemented in the IFD protocol. The best docked poses
were also reproduced by a different docking program, Surflex-
Dock of Sybyl X 2.0 (Tripos Int., St. Louis, MO). All the com-
putationswere undertaken on an IntelXeonTMQuad-core 2.5
GHz workstation with Linux Cent OS release 5.5.
As a positive control of the dockingmethod, IFDof sialic acid
(N-acetylneuraminic acid) and Pse onto Micromonospora
viridifaciens sialidase (PDB code 1EUS) (51) and Pseudomonas
aeruginosa pseudaminidase (PDB code 2W38) (52) was per-
formed. The docked conformation of sialic acid showed a root-
mean-square (r.m.s.) deviation of 1.5 Å from the co-crystallized
2-deoxy-2,3-dideoxy-N-acetylneuraminic acid (a sialic acid
mimic) in M. viridifaciens sialidase (51). The binding mode of
Pse in P. aeruginosa pseudaminidase predicted by the present
docking calculation was very similar to that of the reported
docking result (52). These results validate the present docking
method.
Peptidase Assay by Mass Analysis—As potential substrates,
synthetic muramyl tetrapeptide (-methyl N-acetylmuramic
acid-L-Ala1--D-Glu2-mDAP3-D-Ala4) andmuramyl pentapep-
tide (-methyl N-acetylmuramic acid-L-Ala1--D-Glu2-mDAP3-
D-Ala4-D-Ala5) were prepared as described previously (Fig. 1, A
and B) (53). The analyte (muramyl tetrapeptide or muramyl
pentapeptide) at 5 mM was incubated for 2 h at 37 °C with the
recombinant Csd6 protein (5 M), which was dissolved in 20
mM sodium phosphate, pH 6.0, and 150mM sodium chloride. A
sample solution (1 l) was mixed on the target with a fresh
saturated matrix solution of 2,5-dihydroxy benzoic acid dis-
solved in 0.1% (v/v) trifluoroacetic acid and 50% (v/v) acetoni-
trile. For sample deposition, a 384-position stainless steel
sample plate was used.Mass spectra were acquired on amatrix-
assisted laser desorption/ionization quadrupole ion trap time-
of-flight mass spectrometer (MALDI-QIT-TOF MS, AXIMA
QIT; Shimadzu/Kratos, Manchester, UK) equipped with a
nitrogen laser (337 nm, 3-ns pulse width, maximum pulse rate
of 10 Hz). Mass spectra were obtained in a positive ion mode.
Helium was used for trapping and cooling ions in the ion
source. The pressure in the trap was held at 4 103 torr. Each
spectrum constituted an average of 200 profiles. All spectra
were externally calibrated with bradykinin (757.3992 Da), ang-
iotensin II (1046.5418 Da), angiotensin I (1296.6848 Da), Glu-
fibrinopeptide B (1570.6768 Da), and N-acetyl renin substrate
(1800.9432 Da) in TOFMixTM (Shimadzu, Japan). Acquisition
and data processing were controlled by the LanchpadTM soft-
ware. Them/z values of multiple sodium adduct ions from the
substrates and products are shown in Fig. 1, A–E. As a positive
control, the peaks were detected corresponding to the dimeric
cross-linked species between the muramyl tetrapeptide and
muramyl tripeptide (Fig. 1C), a product of the L,D-TPase reac-
tion catalyzed by the recombinant LdtMt2 (Ala-55–Ala-408).
The L,D-TPase domain (residues Asp-251–Val-378) of M.
tuberculosis LdtMt2 shows sequence identity and similarity of
22 and 38%, respectively, with the Csd6 L,D-CPase domain (res-
idues Lys-67–Glu-202).
To evaluate the importance of specific residues in the L,D-
CPase activity of Csd6, each of seven residues in the active site
was mutated into alanine as follows: E110A, Y132A, Y133A,
H155A,W158A, H160A, and C176A. The mutations were ver-
ified by DNA sequencing. The wild type and these single
mutants of Csd6 were incubated with the substrate muramyl
tetrapeptide for 30 min at 23 °C. Mass spectra were acquired as
described above.
Analytical Ultracentrifugation—To determine the oligomer-
ic state of the recombinant Csd6 in solution, equilibrium sedi-
mentation and sedimentation velocity experiments were car-
ried out using a Beckman ProteomeLab XL-A analytical
ultracentrifuge in 20 mM Tris-HCl buffer, pH 7.9, containing
150mM sodium chloride and 1.5 mM tris(2-carboxyethyl)phos-
phine at 20 °C. For the equilibrium sedimentation experiment,
the absorbance from the Csd6 samples was measured at 235
and 280 nm using a six-sector cell at two speeds (16,000 and
20,000 rpm) and at three different Csd6 monomer concentra-
tions (2.74, 3.65, and 4.56 M) with a loading volume of 135 l.
For the sedimentation velocity experiment, theCsd6 samples at
two differentmonomer concentrations (0.40 and 5.00M)were
measured in double-sector cells at 30,000 rpm, and the col-
lected data were analyzed by SEDFIT and SEDPHAT programs
available on line. The concentration of the recombinant Csd6
protein was calculated using 280 nm 54,780 M1 cm1.
Single Molecule Fluorescence Resonance Energy Transfer
(FRET)—To analyze the dimeric form of Csd6 in solution, a
single molecule FRET technique incorporating alternating
laser excitation (ALEX) was employed (54, 55). Briefly, in this
method the fluorescence signal of a dimeric molecule was ana-
lyzed one-by-one, and the result is presented in a two-dimen-
sional E-S graph (Fig. 3A), where E is the FRET efficiency and S
denotes the Cy3/Cy5 molar ratio in a dimer. The Csd6 sample
was divided into 2 aliquots, each of which was labeled on the
sole cysteine residue (Cys-176) with the maleimide-reactive
Cy3 dye (donor) or the Cy5 dye (acceptor). Subsequently, Cy3-
labeled Csd6 (Cy3-Csd6) and Cy5-labeled Csd6 (Cy5-Csd6)
were mixed at 2 M final monomer concentration in a buffer
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(20 mM Tris-HCl, pH 7.9, and 150 mM sodium chloride) for 3 h
at 37 °C.The protein samplewas diluted further to 100 pMusing
a single molecule buffer (20 mM Tris-HCl, pH 7.9, 150 mM
sodium chloride, 5% (v/v) glycerol, 1 mM 2-mercaptoethyl-
amine, and 0.01% (v/v) bovine serum albumin). The singlemol-
ecule data were acquired from a 10-min measurement.
Surface Plasmon Resonance Experiment—The kinetics and
affinity of Csd6 with the synthetic muramyl tetrapeptide and
muramyl tripeptide (-methyl N-acetylmuramic acid-L-Ala1-
-D-Glu2-mDAP3) as a reaction product were assessed using a
Reichert SR7500 surface plasmon resonance (SPR) dual chan-
nel instrument (Reichert, Depew, NY). Purified Csd6 in 20 mM
sodium acetate, pH 5.5, was immobilized using the standard
amino coupling at 20 l min1 on a carboxymethyl dextran
hydrogel surface sensor chip (Reichert, Depew, NY) until satu-
ration was achieved. The running buffer B used in all SPR
experiments was 20 mM HEPES, pH 7.9, and 150 mM sodium
chloride. SPR experiments were performed at 25 °C. The
muramyl tetrapeptide or muramyl tripeptide at concentrations
of 15.6, 31.3, 62.5, 125, 250, and 500 M was injected over the
Csd6-chip at 30 l min1 for 5 min for association analyses.
Subsequently, the running buffer was flowed over the chip for
an additional 6 min (30 l min1) for dissociation analyses.
Regeneration of the chip was carried out using 20 mM sodium
hydroxide. Binding was detected as a change in the refractive
index at the surface of the chip as measured by the response
unit. A reference flow cell was used to record the response by
bovine serum albumin (BSA) as a positive control, and the
response by BSA was subtracted from each sample. SPR data
were fit using the Scrubber2 software.
Results
Csd6 Functions as an L,D-CPase but Not as an L,D-TPase—To
verify themolecular function ofH. pyloriCsd6 in peptidoglycan
modification, the peptidase activity of Csd6 was measured in
vitro with the synthetic muramyl tetrapeptide and muramyl
pentapeptide (Fig. 1,A andB) as potential substrates usingmass
analyses. When the muramyl pentapeptide was incubated with
the recombinant Csd6(13–330), no reaction product could be
detected (Fig. 1C). This suggests that Csd6 does not have
“endo”-, “D,D-carboxy”-, or “L,D-trans”-peptidase activities with
the muramyl pentapeptide. The L,D-CPase domain of Csd6
shows limited but significant sequence identity (22%) with the
L,D-TPase domain of M. tuberculosis LdtMt2. M. tuberculosis
LdtMt2 is a functional L,D-TPase, catalyzing the formation of
333 cross-links between the muramyl tetrapeptide and the
muramyl tripeptide (56). Therefore, as a positive control for
measuring the L,D-TPase activity, the muramyl tetrapeptide
was incubated with the recombinantM. tuberculosis LdtMt2. In
this control reaction, not only the muramyl tripeptide (Tri in
Fig. 1C) but also the dimeric cross-linked species (Tetra-Tri
in Fig. 1C) were detected as the reaction products. In compar-
ison, when the muramyl tetrapeptide was incubated with the
recombinant Csd6, the muramyl tripeptide was detected as the
sole reaction product of trimming without any dimeric cross-
linked species (Fig. 1D). This result implies that Csd6would not
be active for cross-linking, if the muramyl tripeptide were used
as a substrate. The present data, together with the previous
report that Csd6 converts monomeric tetrapeptides of the pep-
tidoglycan sacculus into tripeptides (23), clearly establish that
FIGURE 1. L,D-CPase activity of Csd6. A and B, mass spectra and structural formulas of the synthesizedmuramyl tetrapeptide (A) andmuramyl pentapeptide
(B). The observed peaks correspond to a series of sodium adduct ions of the peptides. C–E, mass spectra of the peptide samples upon incubation with LdtMt2
and Csd6. In the control reaction catalyzed by LdtMt2, the dimeric cross-linked tetra-tripeptide species is produced from the muramyl tetrapeptide (C). In
contrast, in the reaction catalyzed by Csd6, the muramyl tetrapeptide is converted to the muramyl tripeptide but not to dimeric cross-linked tetra-tripeptide
species (D). Upon incubation with Csd6, the muramyl pentapeptide undergoes no change (E). The observed m/z values for the charged species with bound
sodium ions (up to four: [M Na]1, [M 2Na-H]1, [M 3Na-2H]1, and [M 4Na-3H]1) agree with the calculated m/z values for muramyl tri-, muramyl
tetra-, muramyl penta-, or dimeric cross-linked tetra-tripeptides (average relative mass of neutral species 679.67, 750.75, 821.83, or 1412.41, respectively).
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H. pyloriCsd6 functions as an L,D-“carboxypeptidase” devoid of
a cross-linking L,D-TPase, despite the presence of the conserved
Cys/His residues, which are characteristics of the L,D-TPase
domains. The active-site features of Csd6, as discussed in more
detail below, explain why Csd6 is inactive as L,D-TPase.
Csd6 Monomer Is Organized into a Three-domain Archi-
tecture—To provide a structural basis of understanding the
molecular function, the crystal structures of Csd6 have been
determined, both in the ligand-free state (“Csd6-unbound”)
(Fig. 2A) and in the D-Ala-bound state (“Csd6-Ala”) (Table 1).
Refined models of both structures are essentially identical to
each other with an r.m.s. deviation of 0.17 Å for 632 eq C
positions. They account for residues Met-15–Lys-330 in each
of two Csd6 monomers in an asymmetric unit (ASU). In the
case of Csd6-unbound structure, two monomers in the ASU
were similar to each other with an r.m.s. deviation of 0.64 Å for
316C atompairs, except for theN-terminal residues (Leu-15–
Asp-41) showing r.m.s. deviations greater than 1.0 Å with a
maximum C deviation (7.6 Å) at Leu-15. For the Csd6-Ala
model, twomonomers in theASUagreewith an r.m.s. deviation
of 0.61 Å for 316 C atom pairs, except for the N-terminal
residues (Leu-15–Asp-41) showing r.m.s. deviations greater
than 1.0Åwith amaximumC deviation (8.1 Å) at Leu-15. The
amino acid residues with the largest deviation encompass the
entire helix A and the N-terminal half of B.
The Csd6 monomer consists of three domains of unequal
sizes as follows: the NTD (Val-13–Asn-56), the middle L,D-
CPase domain (Lys-67–Glu-202), and the C-terminal NTF2-
like domain (Thr-209–Lys-330) (Fig. 2A). The NTD consists
of three -helices (A–C), and the helix C is positioned at
one end of the antiparallel coiled-coil formed by helices A
and B. The L,D-CPase domain consists of two curved
-sheets (32-21-12-82-41 and 41-52-
61-71), which share the4-strand, as well as two-heli-
ces (D and E). The NTF2-like domain forms an antiparal-
lel four-stranded -sheet (92-101-112-121),
whose concave side is packed by three -helices (F–H).
DALI structural similarity searches (57) revealed no signifi-
cant match with either the entire Csd6 with three domains or
any combination of two connected domains in Csd6, sug-
gesting that the three-domain architecture of Csd6 is
unique. This is in line with our observation that the organi-
zation of the L,D-CPase domain and the NTF2-like domain in
Csd6 and its homologs is unique among the L,D-TPase and
FIGURE 2. Overall structure and the oligomeric state of H. pylori Csd6. A, ribbon diagram (upper panel) and topology diagram (bottom panel) of the
Csd6-unboundstructure. TheNTD, L,D-CPasedomain, andNTF2-likedomainare shown in red, green,and yellow, respectively. The secondary structureelements
have been defined by the DSSP program (77). The nucleophile Cys-176 of the L,D-CPase domain is shown in a cyan stickmodel. B, equilibrium sedimentation
data for Csd6 at an ultracentrifugal speed of 16,000 rpmusing 3.65Mprotein at 20 °C. The circles are experimental data, and the solid line is a fitting line for an
idealmonomermodel. The two dotted lines are fitting lines for idealmonomer and trimermodels. Distributions of the residuals formonomer, dimer, and trimer
models are shown in the inset panel. These data indicate that Csd6 exists as homogeneous dimers in solution. C, two putativemodels of the Csd6 dimer in the
crystal. Dimer model I (upper panel) and model II (bottom panel) are shown in ribbon diagrams. The side chain sulfur atoms of Cys-176 are shown as purple
spheres. Model I is favored by the singlemolecule ALEX-FRET data (shown in Fig. 3A).D, plots of the residuals for dimer speciesmodel of Csd6 at 0.40M (upper)
and 5.00M (lower), and the distribution of sedimentation coefficient (c(s) versus s, where s is in Svedberg unit, S) from the sedimentation velocity experiments.
Crystal Structure of Csd6 fromHelicobacter pylori
25108 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 41•OCTOBER 9, 2015
L,D-CPase families according to the conserved domain
searches using the InterPro database (58).
In the Csd6monomer structure, three domains are arranged
in a tripartite leaf-like fashion with a single chain connecting
two adjacent domains (Fig. 2A). Virtually no interaction exists
between theNTDand the L,D-CPase domain; the buried surface
area at the interface is only 36 Å2, as calculated by the PISA
server (59). Much more extensive interactions exist between
the L,D-CPase domain and the NTF2-like domain, with a
buried surface area of 718 Å2. The latter interface is mainly
formed between strands 4 and 8 of the L,D-CPase domain
and strands 9–11 of the NTF2-like domain. It is primarily
lined with hydrophobic residues of both domains (Val-119,
Tyr-120, Tyr-146, Phe-197, and Ile-199 of the L,D-CPase
domain and Ile-278, Tyr-280, Tyr-290, Val-292, and Tyr-316 of
theNTF2-like domain). TheNTD (helixC) and theNTF2-like
domain (helix F) interact with each other, burying a surface
area of 410 Å2 at the interface.
NTD of Csd6 Plays a Dominant Role in Homodimerization—
Equilibrium sedimentation measurements indicate that the
Csd6 protein exists as a homogeneous dimer in solution (at the
tested Csd6 monomer concentration range of 2.74–4.56 M).
The data fit well to a dimer model, and a representative result
measured at 16,000 rpm using the 3.65 M monomer concen-
tration is presented in Fig. 2B. Further sedimentation velocity
experiments at 0.40 and 5.00 M Csd6 monomer concentra-
tions also indicate the oligomeric state of Csd6 as a dimer, with-
out any discernable dissociation of a dimer into monomers,
down to 0.40 M (Fig. 2D). In the crystal of Csd6, two possible
models of the dimer could be identified. The dimer model I has
a buried surface area of 1,080 Å2 per monomer (6.7% of the
monomer surface area) at the interface, as analyzed by the PISA
server (Fig. 2C, upper panel) (59). In the dimer model I, the two
monomers are related by noncrystallographic “pseudo” 2-fold
symmetry. The 2-fold symmetry is broken primarily by the sig-
nificant difference in the orientation of N-terminal helices A
and B between the two monomers. The dimer model II has a
buried surface area of 726 Å2 (4.5% of the monomer surface
area) (Fig. 2C, lower panel). In the dimer model II, the two
monomers are related by an exact crystallographic 2-fold sym-
metry. The iG values (solvation free energy gain upon forma-
tion of the interface) are15.8 and2.1 kcal mol1 formodels
I and II, with the complexation significance scores of 1.000 and
0.000, respectively. These complexation significance score val-
ues imply that the interface inmodel I, but not inmodel II, plays
an essential role in complex formation. Therefore, we conclude
that the dimer model I in the crystal represents the biologically
relevant Csd6 dimers in solution. This conclusion is supported
experimentally by the distance between two Cys-176 residues
in the dimer as estimated using the single molecule ALEX-
FRET technique (Fig. 3A). The single molecule ALEX-FRET
experiment was performed at 100 pMmonomer concentration,
which is much lower than that used for analytical ultracentrif-
ugation, to avoid ensemble averaging (i.e. to avoid the case of
having two noninteracting species) (60). After direct excitation
leakage and buffer background corrections, the distance
TABLE 1
Data collection and refinement statistics
A. Data collection
Data set EMTS peak Csd6-unbound Csd6-Ala
Beamline sourcea PLS BL-4A PF BL-1A PLS BL-5C
Space group P212121 P212121 P212121
a, b, c (Å) 61.8, 89.6, 128.7 63.0, 91.0, 127.8 63.4, 90.6, 127.9
X-ray wavelength (Å) 1.0048 1.0000 0.9796
Resolution rangeb (Å) 50.0–2.90 (2.95–2.90) 50.0–2.03 (2.07–2.03) 50.0–2.04 (2.08–2.04)
No. of total reflectionsb 373,689 (18,354) 229,193 (11,715) 227,623 (11,074)
No. of unique reflectionsb 30,311 (1,515)c 47,555 (2,343) 47,575 (2,307)
Completeness (%)b 99.9 (100)c 98.3 (98.1) 99.9 (100)
I/Ib 35.0 (4.7)c 25.0 (3.0) 29.3 (3.4)
Wilson B factor (Å2) 53.1 34.2 30.5
Rmergeb,d (%) 11.0 (73.1)c 9.5 (47.0) 8.6 (53.7)
B. SAD phasing Figure of merit (before/after density modification) 0.34/0.66
C. Model refinement
PDB ID code 4XZZ 4Y4V
Resolution range (Å) 30.0–2.03 20.0–2.04
Rwork/Rfreee (%) 19.6/24.8 19.1/24.2
No. of non-hydrogen atoms/average B-factor (Å2)
Total 5,589/40.6 5,606/37.8
Protein 5,248/40.4 5,249/38.7
Water oxygen 323/41.5 315/40.5
Glycerol 18/63.4 24/58.9
D-Ala / 18/44.6
R.m.s. deviations from ideal geometry
Bond lengths (Å)/angles (°) 0.009/1.33 0.010/1.39
R.m.s. Z-scores
Bond lengths (Å)/angles (°) 0.46/0.61 0.49/0.65
Ramachandran (%)f
Favored/outliers 98.6/0.00 98.4/0.00
Poor rotamers (%)f 0.00 0.70
a PF and PLS stand for Photon Factory, Japan, and Pohang Light Source, Korea, respectively.
b Values in parentheses refer to the highest resolution shell.
c Friedel pairs were treated as separate observations.
d Rmerge 	h	iI(h)i I(h)/	h	iI(h)i, where I(h) is the intensity of reflection h; 	h is the sum over all reflections, and 	i is the sum over imeasurements of reflection h.
e Rwork 	Fobs  Fcalc/	Fobs, where Rfree is calculated for a randomly chosen 5% of reflections, which were not used for structure refinement, and Rwork is calculated for
the remaining reflections.
f Values were obtained using MolProbity.
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between Cy3 and Cy5 dipoles in the dye-labeled Csd6 dimer is
estimated to be 107Å from the corrected FRET efficiency (Ecorr

0.03), using Ro (Förster distance) of 60 Å for the Cy3 and Cy5
pair. In the crystal structure of Csd6-unbound, the distance
between sulfur atoms of two Cys-176 residues is 96 and 66 Å in
dimer models I and II, respectively. This result unambiguously
favors model I, supporting the assignment of dimer model I in
the crystal as the dimer in solution (Fig. 2C, upper panel).
The Csd6 dimer (i.e. dimer model I) is elongated with
approximate dimensions of 100  80  50 Å (Fig. 3B). In this
dimer, two L,D-CPase domains are well separated from each
other, and their active sites are open toward the bulk solvent
(Fig. 3B). The bulk of the buried surface area at the dimerization
interface is contributed by the NTD (82.7%), with the linker
between the NTD and the L,D-CPase domain contributing 5.7%
and theNTF2-like domain contributing 11.6%. TheN-terminal
helix A of the NTD takes slightly different conformations in
the two monomers, with a maximum C deviation of 8.1 Å at
Leu-15. The two NTDs pack against each other through their
antiparallel coiled-coils (helices A and B), at an angle of
about 60°, to form a four-helix bundle (Fig. 3B); numerous
hydrophobicsidechainsarepresentattheinterface.TheC-heli-
ces from two NTDs cover the sides of the four-helix bundle.
Seven hydrogen bonds (involving Arg-26, Tyr-28, Gln-29, Gly-
37, Asp-41, Glu-53, Tyr-63, Gln-65, and Phe-272) and a salt
bridge (involving Arg-26 and Glu-53) exist at the interface (Fig.
3C). Interestingly, the Csd6 dimer has a deep crevice of an
approximate size of 20  20 Å, with a widened bottom (indi-
cated by dotted lines in Fig. 3D). The NTDs provide the bottom
of the crevice, and the C-terminal NTF2-like domains form the
two sides of the crevice. The sides of the crevice are lined with
positively charged residues (Lys-267, Lys-298, and Lys-304) but
no negatively charged residues (Fig. 3D).
A DALI search with the Csd6 NTD (Val-13–Asn-56) alone
showed very remote structural similarities to other known pro-
tein structures. The highest Z-score was obtained with human
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic sub-
unit  isoform (PDB code 4L2Y-A; an r.m.s. deviation of 2.1 Å
for 41 equivalent C positions in residues 16–56, a Z-score of
4.6, and a sequence identity of 5%). The Csd6 NTD is perhaps
functionallymore related to the L27Ndomain ofMusmusculus
PALS1-associated tight junction protein (PDBcode 1VF6-D; an
r.m.s. deviation of 4.2 Å for 41 eq C positions in residues
16-56, aZ-score of 4.3, and a sequence identity of 12%) (61). L27
domains, such as PALS1-L27N, have been established as a pro-
tein-binding module that brings multiple proteins into com-
plexes for signaling, cell polarity, and epithelial morphogenesis
(62, 63). Like the Csd6 NTD, the L27 domain is composed of
three-helices. However, unlike the Csd6NTD that plays a key
role in homodimerization, two different L27 domains (e.g.
PALS1-L27N domain and PATJ-L27) heterodimerize by build-
ing a compact four-helix bundle structure through the first two
helices from each L27 domain (61).
Active-site of Csd6 L,D-CPase Domain Is Tailored for the L,D-
CPaseActivity—Abioinformatics analysis on the basis of amino
acid sequence predictsH. pylori Csd6 to have an overall fold of
the L,D-TPase catalytic domain over residues 67–200. The
structure reported here validates this prediction (Figs. 2A and
4A). However, this catalytic domain is referred to as the L,D-
CPase domain, because Csd6 is shown to function only as an
L,D-CPase and not as an L,D-TPase against the muramyl tetra-
peptide. According to the DALI search, the overall fold of the
Csd6 L,D-CPase domain (Lys-67–Glu-202) (Fig. 4A) resembles
those of well characterized L,D-TPases such as B. subtilis LdtBs
(Fig. 4B) (PDB code 1Y7M; aZ-score of 14.8, an r.m.s. deviation
of 1.8 Å, and a sequence identity of 13% for 109 equivalent C
positions) (64), E. faecium Ldtfm (Fig. 4C) (PDB code 1ZAT; a
Z-score of 12.1, an r.m.s. deviation of 2.7 Å, and a sequence
identity of 14% for 111 eq C positions) (29), and M. tubercu-
losis LdtMt2 (Fig. 4D) (PDB code 4GSU; a Z-score of 11.7, an
r.m.s. deviation of 2.1 Å, and a sequence identity of 14% for 107
eq C positions) (30). Unlike Csd6, all of these L,D-TPases are
monomeric enzymes (29, 30, 64). Furthermore, the L,D-CPase
domain of Csd6 contains the characteristic sequence motif
H(S/G/D)X14–19C (Fig. 4E), where X stands for any amino acid
and the strictly conserved residues are in boldface. Thismotif is
FIGURE 3. Dimeric structure of H. pylori Csd6. A, determination of the
dimeric model of Csd6 by single molecule FRET technique. Single molecule
FRET data are presented in a two-dimensional E-S graph, where E is the FRET
efficiency and Sdenotes theCy3 (donor)/Cy5 (acceptor)molar ratio in adimer
(54). Three clusters correspond to the dimers formed as follows: (i) between
two Cy3-Csd6 monomers; (ii) between two Cy5-Csd6 monomers; and (iii)
between a Cy3-Csd6 monomer and a Cy5-Csd6 monomer. The cluster
appearing at S  1 (green dotted ellipse) with E 
 0 corresponds to Cy3-
labeled Csd6 dimers. Csd6 dimers labeled with both Cy3 and Cy5 appear
at S  0.5 (orange dotted ellipse) (55). B, ribbon diagram of the Csd6
homodimer (model I) colored as in Fig. 2A. In this dimer, A and B mono-
mers are related by a noncrystallographic pseudo 2-fold symmetry. C,
hydrophobic interactions between the NTDs of A and B monomers, which
are shown in the ribbon diagram and the electrostatic surface diagram,
respectively. D, electrostatic potential surface diagrams of the Csd6 dimer
molecule. A detailed view of the specific hole formed by the dimerization
is shown in the black lined box.
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conserved among proteins containing an L,D-TPase catalytic
domain and provides the catalytic triad residues, which form a
hydrogen bond network in a wide range of Cys/Ser-based pro-
teolytic enzymes (65). The catalytic triad of Csd6 consists of
His-160, Gly-161, and Cys-176 (marked by red dots in Fig. 4E),
corresponding to His-336, Ser-337, and Cys-354 of LdtMt2 (30).
However, H. pylori Csd6 is unrelated in its sequence and
structure to previously characterized L,D-CPases such as L,D-
carboxypeptidases A (LdcA) from P. aeruginosa (66) and
Novosphingobium aromaticivorans DSM 12444 (67), and L,D-
carboxypeptidases B (LdcB) from Streptococcus pneumoniae,
Bacillus anthracis, and Bacillus subtilis (68). LdcA is a Ser-
based L,D-CPase. The latter three LdcB proteins belong to the
LAS (lysostaphin, D-Ala-D-Ala metallopeptidases, sonic hedge-
hog) family of Zn2-dependent peptidases (68). This raises an
intriguing question why H. pylori Csd6 functions only as an
L,D-CPase, and not as an L,D-TPase, despite the overall L,D-
TPase fold and the presence of the conserved catalytic triad.
A structural comparison of Csd6 L,D-CPase domain with L,D-
TPase domains reveals that the shape of the active site in the
Csd6 L,D-CPase domain seems to be tailored for the L,D-car-
boxypeptidation, i.e. the active site is a deep pocket and the
catalytic triad positioned at the bottom of this pocket is acces-
sible via a single narrow path (Fig. 4A), as in typical carboxy-
peptidases (69). In contrast, the active site in the corresponding
domains of the above three L,D-TPases is an elongated groove,
and the catalytic triad is accessible via two paths (Fig. 4, B–D)
(30). The different shapes of the active sites are primarily dic-
tated by the length and conformation of the loops around the
entrance(s) to the active sites. Structural comparison and
sequence alignment of the Csd6 L,D-CPase domain with the
corresponding domains of three L,D-TPases (Fig. 4) show that
FIGURE 4. Comparison of Csd6 and three L,D-TPases. A–D, the ribbon diagrams (left panels) and surface diagrams (right panels) of the L,D-CPase domain ofH.
pyloriCsd6 (A) and the L,D-TPasedomains ofB. subtilis LdtBs (B), E. faecium Ldtfm (C), andM. tuberculosis LdtMt2 (D). The four loops I–IV are colored in yellow, green,
purple, and light blue, respectively. One or two paths that allow access to the catalytic triad are indicated by red arrows. In the meropenem-complexed
LdtMt2 structure (PDB code 4GSU), the paths A and B correspond to left and right arrows, respectively (30). Meropenem was modeled into each domain
structure by structural superimposition of the corresponding domains using the meropenem-complexed LdtMt2 (PDB code 4GSU). E, structure-based
sequence alignment was performed by PROMALS3D (80), and the alignment was presented by GeneDoc. Structures of the L,D-CPase domain of H. pylori
Csd6 (Swiss-Prot accession code O25255; PDB code 4XZZ) and L,D-TPase catalytic domains of B. subtilis LdtBs (O34816; 1Y7M), E. faecium Ldtfm (Q3Y185;
1ZAT), and M. tuberculosis LdtMt2 (O53223; 4GSU) were used in the alignment. In the case of C. jejuni Pgp2 (A1VZP0), no structural information was
available, and thus only the sequence is used. Red dots indicate the catalytic triad (His-160, Gly-161, and Cys-176 in H. pylori Csd6). The four loops I–IV are
shown in colored boxes as in A.
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unique features of Csd6 that distinguish it from other L,D-
TPases reside primarily in the following four loop regions: loop
I (3-4 loop; Ala-98–Ile-117); loop II (4-5 loop; Leu-126–
Leu-136); loop III (5-D-6 loop; Asn-141–Ile-157); and loop
IV (6-7 loop; Met-162–Cys-176).
The reaction catalyzed by L,D-TPases such as LdtMt2 occurs
in two sequential steps as follows: acylation of the donor sub-
strate (“carboxypeptidation”) and deacylation by the acceptor
substrate for cross-linking (“transpeptidation”) (70). As a con-
sequence, L,D-TPases such as LdtMt2 have two accessible paths
for donor and acceptor substrates (indicated by red arrows in
Fig. 4, B–D), thereby allowing an approach of the acceptor sub-
strate upon acylation of the donor substrate by the catalytic Cys
residue for transpeptidation. For a better understanding of the
substrate-binding site (Fig. 4, A–D), meropenem (mimicking
the substrate) was modeled into Csd6 by superimposing its L,D-
CPase domain and the L,D-TPase domain of the meropenem-
complexed LdtMt2 (30). The position of the covalently bound
meropenem represents the path for the donor substrate (“path
A”). The active-site clefts in three L,D-TPases reveal a long
groove for binding two substrates, which is contributed by the
four loops I–IV (Fig. 4,B–D). In LdtMt2 and Ldtfm, the extended
loop II (green colored in Fig. 4,C andD) forms a lid to cover the
active-site cleft, while exposing twodiscrete paths for the access
of two substrates. However, the loop II of LdtBs ismuch shorter,
and the active-site cleft is not covered with a lid (green colored
in Fig. 4B). Like LdtBs, the loop II is much shorter in Csd6, and
the active-site cleft is not covered with a lid. Moreover, in the
Csd6 structure, the corresponding paths to the active-site cleft
for access of two substrates in three L,D-TPases are blocked due
to the distinct length and conformations of the loops I–IV, and
the active-site cleft opens vertically toward the solvent (indi-
cated by a red arrow in Fig. 4A), allowing access of only one
muramyl peptide for carboxypeptidation. This difference in the
shape of the active-site cleft is the likely reason for the enzyme
serving as a carboxypeptidase, to the exclusion of the transpep-
tidase activity.
Among the four loops I–IV, the loops I and III show themost
distinct variations in sequence length and conformation. They
are considerably longer (8 and 12 residues, respectively) in H.
pylori Csd6 than in the L,D-TPases (Fig. 4E). Loop III contains
the helix D, which protrudes from the active site. Together
with loop I, it provides one side of the active-site cleft to recog-
nize a substrate. The C. jejuni Pgp2, a Csd6 homolog, is pre-
dicted to contain an L,D-TPase domain on the basis of its amino
acid sequence (Fig. 4E), but it was shown to function as an
L,D-CPase (26). We notice that the four loops of Pgp2 show a
highly similar pattern with those of Csd6 (Fig. 4E). Therefore, it
is anticipated that the observed unique structural features of
these four loops around the active-site cleft are conserved
among Csd6 homologs in other -proteobacteria.
D-Ala-complexed Structure Reveals Binding Modes of Both
the Substrate and Product—By analogy with the first carboxy-
peptidation step of LdtMt2, His-160 of Csd6 serves as a proton
acceptor to assist a nucleophilic attack by Cys-176. In the pres-
ent Csd6 structure, the side chains of His-160 and Cys-176 are
suitably predisposed for a cooperative action with the main-
chain carbonyl of Gly-161 (Fig. 5A). His-160N2 interacts with
Cys-176S with a distance of 3.96 Å and His-160N	1 interacts
with the main-chain oxygen atom of Gly-161 with a distance of
2.75 Å (Fig. 5A). In addition, the L,D-CPase domain of Csd6
shows a well defined oxyanion hole to facilitate catalysis. The
backbone amide nitrogen atoms of Lys-174, Gly-175, and Cys-
176 (asterisks in Fig. 5A) could stabilize the transient oxyanion
species of the polarized carbonyl bond, as in LdtMt2 (70).
To understand the structural determinants for ligand bind-
ing, the structure of Csd6 bound with the reaction product
D-Ala (Csd6-Ala in Table 1) was determined. In the Csd6-Ala
model, two D-Ala molecules are well ensconced within the
active site ofmonomerAwith clear electron density (marked as
D-Ala and D-Ala in Fig. 5A), whereas only one D-Ala molecule
is present in monomer B at the corresponding position as
D-Ala in monomer A. The different binding states of mono-
mers A and B in the crystal seem to be correlated with the
oxidation state of Cys-176. Its side chain is oxidized to sulfenic
acid only in monomer A, as indicated by the extra electron
density (C176OH in Fig. 5A). An oxygen atom of sulfenic acid
possibly stabilizes the weak binding of the product D-AlaN in
monomer A. D-Ala is located between loops I and III, whereas
D-Ala is trapped by loops II–IV, right in front of the nucleo-
phile Cys-176. D-Ala is too far from the predicted site of the
scissile bond for Cys-176 to act, but it interacts with Lys-107N
,
Glu-110O2, His-155N,O,N	1, andGly-111N, as well as Lys-174N,
and the main-chain oxygen atom of Leu-113 via a water mole-
cule. Interestingly, the side-chain portion ofmDAP, part of the
Csd6 substrate muramyl-L-Ala1--D-Glu2-mDAP3-D-Ala4, is
structurally identical to a D-Ala molecule. Therefore, we sug-
gest that D-Ala and D-Ala represent the portion of the sub-
strate and the end product, D-Ala, respectively, for the link
between mDAP3 and D-Ala4 (the scissile peptide bond) of the
muramyl tetrapeptide. mDAP was modeled into the Csd6 L,D-
CPase domain on the basis of the positions of D-Ala andWat1
bound in the oxyanion hole. The modeledmDAP fits well into
the active-site cleft (bottom panel of Fig. 5A). It makes proper
interactions with the oxyanion hole and is suitably positioned
for a nucleophilic attack by Cys-176, thus providing the sub-
strate-binding mode. Dissociation constants (KD) of Csd6 for
its complex with D-Ala (ormDAP) have also been measured to
be 224 (or 94) M using SPR measurements. The measured
association and dissociation rate constants (ka and kd) are 1.05
M
1 s1 and 2.30  104 s1 for D-Ala and 1.49 M1 s1 and
1.40 104 s1 formDAP, respectively.
To further confirm the role of potential key residues in the
active-site cleft, seven single amino acid mutant proteins
(E110A, Y132A, Y133A, H155A, W158A, H160A, and C176A)
were prepared. When the L,D-carboxypeptidation activities of
the wild-type Csd6 and themutants against the muramyl tetra-
peptide for a limited time (30min) were compared,mutation of
Glu-110, Tyr-133, His-155, and Trp-158, as well as His-160 and
Cys-176 that belong to the catalytic triad, resulted in a complete
loss of the L,D-carboxypeptidation activity (Fig. 5B). Glu-110,
Tyr-133, and Trp-158 are strictly conserved inC. jejuni Pgp2 as
well (Fig. 4E). Lack of L,D-carboxypeptidation activity in E110A
and H155Amutants supports that Glu-110 and His-155 recog-
nize the side chain ofmDAP, as shown in D-Ala bound to Csd6
andmDAP modeled into the position of D-Ala (Fig. 5A). Trp-
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158 holds the aliphatic side chain of D-Ala, whereas Tyr-133
likely interacts with the main chain of mDAP, possibly via a
water molecule such as Wat2 in Fig. 5A. Meanwhile, the
retained activity of the Y132Amutant indicates that Tyr-132 is
not important for the L,D-carboxypeptidation activity of Csd6
(Fig. 5B). The L,D-carboxypeptidation activity of Csd6 is inde-
pendent of metal ions, as there is no change upon EDTA treat-
ment (Fig. 5B).
To estimate the kinetics and affinity of Csd6 with the
muramyl tetrapeptide (as a substrate) and muramyl tripeptide
(as a product), SPR experiments were conducted. The associa-
tion rate constant (ka) and the dissociation rate constant (kd) for
themuramyl tripeptide are roughly 3 and 50 larger than those
for the muramyl tetrapeptide, respectively (Fig. 5C). As a con-
sequence, the KD values for the muramyl tetrapeptide and the
muramyl tripeptide are 27.0 and 510 M, respectively, indicat-
ing that the muramyl tripeptide dissociates readily from Csd6
as the product of Csd6-catalyzed L,D-CPase reaction. This
result is also consistent with the muramyl tripeptide not being
used as the substrate for the possible L,D-TPase cross-linking
reaction in the subsequent step.
C-terminalNTF2-likeDomainHas a Putative Binding Pocket
for Pseudaminic Acid—H. pylori Csd6 is distinct from the
known L,D-TPases by having a C-terminal NTF2-like domain
(residues Thr-209–Lys-330), following its L,D-CPase domain.
The combination of these two domains is conserved in the so-
called ErfK/YbiS/YcfS/YnhG family proteins from bothHelico-
bacter and Campylobacter species (Fig. 6). It was reported that
csd6 gene-deficient transposonmutants ofH. pyloriG27 exhib-
ited altered motility in comparison with its parental strain, and
the altered pattern of motility resulted from elevated levels of
O-linked FlaA Pse-glycosylation of flagellin (40). H. pylori
flagellin filaments are post-translationallymodified by glycosyl-
ation with Pse, a nine carbon sugar derivative that resembles
sialic acid, which is typically found onmammalian cell surfaces
(Fig. 7B) (37, 38). The transposon insertions causing the altered
motility were located at either positions765 or803 bp from
the 5 terminus of the csd6 gene (40), corresponding to the
region encoding the NTF2-like domain. Furthermore, the
recombinant H. pylori G27 Csd6 protein expressed in E. coli
was capable of deglycosylating the purified FlaA protein (40).
These results suggest a possible function of the Csd6NTF2-like
domain as a deglycosylase, i.e. pseudaminidase.
The present structure shows that the overall fold of the Csd6
NTF2-like domain differs fromother nonviral sialidase or pseu-
daminidase of the six-bladed -propeller fold (52, 71). Instead,
it is shared with other NTF2-like superfamily members such as
theMagnaporthe grisea scytalone dehydratase (72) (PDB code
1IDP; a Z-score of 14.3 and a sequence identity of 8% for 118 eq
C positions), Pseudomonas putida 5-3-ketosteroid isomer-
ase (73) (PDB code 1OPY; a Z-score of 12.0 and a sequence
identity of 8% for 103 eq C positions), and Rhodococcus sp.
naphthalene dioxygenase (74) (PDB code 2B1X; a Z-score of
14.1 and a sequence identity of 7% for 116 eqC positions) (Fig.
7A). None of these enzymes bears any significant sequence or
functional homology to each other, except that they share com-
mon hydrophobic substrates. This suggests that the fold of
NTF2-like proteins may be a suitable scaffold for building a
pocket to bind hydrophobic ligands. Although the Csd6 NTF2-
like domain differs considerably from these enzymes in the
sequence and the potential function, it shares a deep, largely
hydrophobic pocket that is open to the solvent (Fig. 7, A and
C). This potential ligand-binding pocket is lined with
numerous hydrophobic residues (Trp-223, Trp-227, Tyr-
FIGURE 5. D-Ala-complexed Csd6 and key residues for the L,D-CPase activity. A, ribbon diagram and the accessible inner surface of the active site in the
Csd4-Ala structure. The bound D-Ala molecules (D-Ala and D-Ala) (upper panel) and the mDAP (bottom panel) modeled on the basis of D-Ala and Wat1 are
shown in stick models. The omitmFo DFc maps for D-Ala and D-Ala (contoured at 2.0) and the side chain oxygen atom of Cys-176 oxidized as the sulfenic
acid (contoured at 2.5) are colored in blue. The oxyanion hole is asterisked and also shown as blue dotted lines in the bottompanel. Red dotted lines indicate the
interactions among residuesof the catalytic triad.B, L,D-carboxypeptidationactivitiesof thewild-typeCsd6 (with the treatmentof EDTAornot) and themutants
(E110A, Y132A, Y133A, H155A, W158A, H160A, and C176A) with the muramyl tetrapeptide. C, SPR experiments with immobilized Csd6 and the muramyl
tetrapeptide (ormuramyl tripeptide) as ananalyte at different concentrations (15.6, 31.3, 62.5, 125, 250, and500M) are shown in traces coloredasorange, light
blue, purple, green, red, and blue, respectively.
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235, Tyr-239, Phe-243, Tyr-246, Tyr-257, Tyr-297, and
Tyr-307). In addition, four positively charged residues (Arg-
245, Lys-258, Lys-268, and Lys-313), and a negatively
charged residue (Glu-329) are located within the pocket
(Fig. 7D). The bold-face residues are strictly conserved in
Csd6 homologs in -proteobacteria (Fig. 6). The pocket is
somewhat elongated in its shape, unlike hemispherical pock-
ets in scytalone dehydratase and 5-3-ketosteroid isomerase
(Fig. 7, A and C). The Csd6 NTF2-like domain is highly basic
with a calculated pI of 9.4; the electrostatic potential surface
shows a highly positively charged surface around its deep
pocket (Fig. 7A), compared with the above three NTF2-like
superfamily enzymes.
In light of the previous report thatH. pylori Csd6 is involved
in the deglycosylation of flagellin (40) and the presence of a
deep pocket in theNTF2-like domain of Csd6 for possible bind-
ing of a hydrophobic ligand with an acidic group(s) such as Pse,
an in silico docking study has been performed. It shows that Pse
can fit well into the pocket of the NTF-like domain (Fig. 7C).
However, it remains to be determined whether Csd6 has pseu-
daminidase activity.
Discussion
We have determined the first crystal structure of Csd6,
one of the cell shape-determining proteins in H. pylori. Each
of its three domains is associated with a distinct function. The
NTD plays a dominant role in homodimerization. The C-ter-
minal NTF2-like domain has a putative binding pocket for Pse.
The central L,D-CPase domain has the L,D-TPase fold but the
shape of its active-site pocket explains why Csd6 possesses only
the L,D-carboxypeptidation activity, despite the presence of the
conserved catalytic residues for the potential transpeptidase
reaction.
FIGURE 6. Sequence alignment of Csd6 homologs. Sequence alignment of Csd6 homologs from H. pylori strain 26695 (HP0518; Swiss-Prot accession code
O25255), fromWolinella succinogenes (Q7MRJ6), from Arcobacter nitrofigilis (D5V196), from Campylobacter concisus strain 13826 (A7ZCK9), and from Thermov-
ibrio ammonificans (E8T4Z0) was performed and presented by ClustalX (78) and ESPript (79). The secondary structure of Csd6 is presented above the aligned
sequences. The four loops I–IV around the active site of the Csd6 L,D-CPase domain are indicated with boxes colored as in Fig. 4E.
FIGURE7.NTF-likedomainofCsd6.A, ribbondiagramsandelectrostaticpoten-
tial surface diagrams of the NTF-like domains of Csd6, scytalone dehydratase,
5-3-ketosteroid isomerase,andnaphthalenedioxygenase.B, chemicalstructure
of Pse.C andD, in silicodocking of Pse onto the pocket in theNTF-like domain of
Csd6. The potential binding pocket is shown in surface representation (C), and
the residues around the docked ligand are shown as stickmodels (D).
Crystal Structure of Csd6 fromHelicobacter pylori
25114 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 41•OCTOBER 9, 2015
H. pylori Csd6, as well as its close homolog Pgp2 from C.
jejuni, contributes to the helical morphology of the cells. Inter-
estingly,H. pyloriCsd6 andC. jejuni Pgp2 are unrelated in their
sequence and structure to previously characterized L,D-CPases
such as LdcA and LdcB from other microorganisms. They are
thus presumed to form a third family of L,D-CPases. However, it
is currently impossible to assign and distinguish genuine L,D-
TPases from the functional L,D-CPases via bioinformatics anal-
yses of amino acid sequences alone. Our finding that Csd6-
specific active-site loops I and III are much longer than the
corresponding loops in known L,D-TPases (Fig. 4E) enables us
to distinguish L,D-CPases possessing the L,D-TPase fold from
bona fide L,D-TPases. Indeed, when amino acid sequences of
Csd6 homologs in -proteobacteria are aligned, Csd6-specific
loops I and III display high levels of sequence conservation (Fig.
6). In light of this observation, the current annotation of H.
pylori Csd6, as well as its homologs in -proteobacteria, as
belonging to the protein family containing an L,D-TPase cata-
lytic domain needs to be revised. We propose that they should
be classified as a third distinct family of L,D-CPase, as initially
noted by others (75).
Enhanced cell attachment of H. pylori leads to an increased
immune response of the host (76). Too much attachment may
thus be detrimental to the bacterium, suggesting a role for
motility in the proper balance of bacterial levels during infec-
tion. This is intriguing, given thatH. pyloriCsd6 is known to be
involved in regulating motility through trimming of the pepti-
doglycan-derived peptides as an L,D-CPase or through affecting
the Pse glycosylation level of flagellin. This study shows that
the active-site of the Csd6 L,D-TPase domain is tailored to
function as the L,D-CPase, which converts muramyl tetra-
peptides into muramyl tripeptides. As Csd6 is nonfunctional
as L,D-TPase, muramyl tripeptides in the peptidoglycan can-
not be 333 cross-linked.This is consistent with the previous
reports that the Helicobacter peptidoglycan layer lacks 333
cross-links (15, 20, 33). An in silico docking shows that the
Csd6 NTF-like domain presents a potential binding site for
Pse, supporting its role in the control of the glycosylation
level of flagellin. Relaxation of peptidoglycan 433 cross-
linking was reported to promoteH. pylori’s helical shape and
stomach colonization (20). Csd6 plays a critical role in deter-
mining the helical cell shape of H. pylori, because it can limit
the supply of substrates for peptidoglycan 433 cross-link-
ing. In conclusion, our study on themultidomain, multifunc-
tional Csd6 provides further insights into the strategy of H.
pylori for regulating its helical cell shape and motility, which
are crucial for its virulence.
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